DCM Support: cell therapy and circulatory support for dilated cardiomyopathy patients with severe ventricular impairment

DCM Support: cell therapy and circulatory support for dilated cardiomyopathy patients with severe ventricular impairment

Abstract Aims The DCM Support trial (NCT03572660) uses a percutaneous circulatory support device (Impella CP, Abiomed, Danvers, MA, USA) to improve the safety of an intracoronary cell infusion procedure in patients with dilated cardiomyopathy (DCM) and a severely reduced left ventricular ejection fr...

Full description

Bibliographic Details
Main Authors: Alice Reid, Mohsin Hussain, Jessry Veerapen, Rohini Ramaseshan, Russell Hall, Ruth Bowles, Daniel A. Jones, Anthony Mathur
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:ESC Heart Failure
Subjects:
Dilated cardiomyopathy
Cell therapy
Clinical trial, circulatory support
Heart failure
Online Access:https://doi.org/10.1002/ehf2.14393

Internet

https://doi.org/10.1002/ehf2.14393

Similar Items